Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Phio Pharmaceuticals Corp (PHIO)

2.47   -0.09 (-3.52%) 08-13 16:00
Open: 2.54 Pre. Close: 2.56
High: 2.59 Low: 2.36
Volume: 556,767 Market Cap: 14M
Phio Pharmaceuticals Corp., a biotechnology company, focuses on discovering and developing immuno-oncology therapeutics to treat cancer in the United States. The company's lead product candidate is RXI-109, an sd-rxRNA that reduces the expression of connective tissue growth factor, a critical regulator of several biological pathways involved in fibrosis, including scar formation in the skin and eye. The company also develops Samcyprone, a topical formulation of the small molecule diphenylcyclopropenone for the clearance of common warts; and RXI-231, an sd-rxRNA compound targeting tyrosinase for use as a cosmetic ingredient that enhances the appearance of uneven skin tone and pigmentation. In addition, it develops RXI-109 that reduces the progression of retinal scarring. The company has collaborations with the Gustave Roussy and Medigene AG, as well as with Helmholtz Zentrum Mnchen.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.596 - 2.611 2.611 - 2.623
Low: 2.325 - 2.345 2.345 - 2.359
Close: 2.444 - 2.473 2.473 - 2.495

Technical analysis

as of: 2020-08-13 4:37:20 PM
Stoxline posted a STRONG SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.27     One year: 3.70
Support: Support1: 2.19    Support2: 1.82
Resistance: Resistance1: 2.80    Resistance2: 3.17
Pivot: 2.58
Moving Average: MA(5): 2.71     MA(20): 2.55
MA(100): 2.29     MA(250): 7.10
MACD: MACD(12,26): 0.07     Signal(9): 0.07
Stochastic oscillator: %K(14,3): 37.55     %D(3): 52.98
RSI: RSI(14): 47.29
52-week: High: 20.35  Low: 1.60  Change(%): -87.1
Average Vol(K): 3-Month: 152771  10-Days: 80225

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
PHIO has closed above bottom band by 32.7%. Bollinger Bands are 1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 14 Aug 2020
H.C. Wainwright Thinks Phio Pharmaceuticals’ Stock is Going to Recover - Smarter Analyst

Wed, 12 Aug 2020
Phio Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update - PRNewswire

Wed, 12 Aug 2020
Do Analysts Agree on Phio Pharmaceuticals Corp (PHIO) Stock's Target Price? - InvestorsObserver

Wed, 12 Aug 2020
Investors Take Advantage of -3.06% Loss In Phio Pharmaceuticals Corp. (NASDAQ:PHIO) - Stocks Register

Tue, 11 Aug 2020
How Will the Market React to Phio Pharmaceuticals Corp (PHIO) Stock Getting a Bullish Rating - InvestorsObserver

Tue, 11 Aug 2020
Phio Pharmaceuticals Corp. (PHIO) and the Battle of Fundamental vs. Technical - The News Heater

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 6
Shares Float (M) 3
% Held by Insiders 6.76
% Held by Institutions 30.47
Shares Short (K) 109
Shares Short P. Month (K) 196

Stock Financials

EPS -11.267
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.180
Profit Margin
Operating Margin
Return on Assets (ttm) -41.1
Return on Equity (ttm) -77.3
Qtrly Rev. Growth
Gross Profit (p.s.) -0.740
Sales Per Share
EBITDA (p.s.) -1.580
Qtrly Earnings Growth
Operating Cash Flow (M) -9
Levered Free Cash Flow (M) -5

Stock Valuations

PE Ratio -0.22
PEG Ratio
Price to Book value 0.59
Price to Sales
Price to Cash Flow -1.65

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.